September 1, 2016 / 2:58 PM / a year ago

BRIEF-Strategic partner Intega Skin Sciences Inc,acquired by Crescita Therapeutics Inc

Sept 1 (Reuters) - Knight Therapeutics Inc

* As part of Crescita acquisition, it was agreed that $3.0 million of Knight’s secured loan will be repaid

* As part of Crescita deal , it was agreed that interest rate on Knight’s remaining loan balance will be reduced to 9%/year

* Received 645,002 common shares of Crescita in exchange for its intega shares

* Now owns an aggregate of 1.5 million common shares of crescita, representing about 10.9% of outstanding common shares of Crescita

* Strategic partner Intega Skin Sciences Inc, a Montreal-based Dermatology Company, has been acquired by Crescita Therapeutics Inc Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below